Trial intelligence / Profile preview

Surufatinib in Medullary and Radioactive Iodine‑Refractory Differentiated Thyroid Cancer

CTR20150824Phase 2Completed

Sponsor

HUTCHMED

Start

Dec 2015

Modality

Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules, Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules

Countries

1